Literature DB >> 21300679

Injection site and risk of medically attended local reactions to acellular pertussis vaccine.

Lisa A Jackson1, Onchee Yu, Jennifer C Nelson, Clara Dominguez, Do Peterson, Roger Baxter, Simon J Hambidge, Allison L Naleway, Edward A Belongia, James D Nordin, James Baggs.   

Abstract

OBJECTIVE: To assess whether the risk of medically attended local reactions to the fifth dose of the diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine varies according to injection site (arm versus thigh).
METHODS: We conducted a retrospective cohort study of children aged 4 through 6 years in the Vaccine Safety Datalink population who received a DTaP vaccination during the period from 2002 through 2006. Medically attended local reactions to the DTaP vaccine were presumptively identified from administrative data and were confirmed by medical record review.
RESULTS: Among the 233,616 children in the study population, 1017 (0.4%) had a confirmed medically attended local reaction to the fifth dose of the DTaP vaccine. The rate of those reactions was significantly higher with vaccinations given in the arm (47.4 per 10,000 vaccinations) compared with vaccinations given in the thigh (32.1 per 10,000 vaccinations) (P < .001). In a multivariable analysis adjusted for age, gender, and study site, children vaccinated in the arm had a 78% higher risk of a local reaction (relative risk: 1.78 [95% confidence interval: 1.43-2.21]).
CONCLUSIONS: Local reactions to the fifth dose of the DTaP vaccine that require medical evaluation are uncommon, but the risk of those reactions is significantly higher when the vaccine is injected in the arm. These findings suggest that the thigh should be considered as an acceptable site of injection for this vaccination.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21300679     DOI: 10.1542/peds.2010-1886

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

1.  Effect of alcohol skin cleansing on vaccination-associated infections and local skin reactions: a randomized controlled trial.

Authors:  Horace Wong; Corinne Moss; Steven M Moss; Vibhuti Shah; Scott A Halperin; Shinya Ito; Priyanjali Mithal; Angie Qu; Anna Taddio
Journal:  Hum Vaccin Immunother       Date:  2019-01-16       Impact factor: 3.452

2.  Adverse Reactions to Pneumococcal Vaccine in Pediatric and Adolescent Patients with Sickle Cell Disease.

Authors:  Jin Han; Opeyemi Kemiki; Lewis L Hsu; Angela E Rivers
Journal:  Pharmacotherapy       Date:  2015-06-19       Impact factor: 4.705

3.  The use of natural language processing to identify Tdap-related local reactions at five health care systems in the Vaccine Safety Datalink.

Authors:  Chengyi Zheng; Wei Yu; Fagen Xie; Wansu Chen; Cheryl Mercado; Lina S Sy; Lei Qian; Sungching Glenn; Gina Lee; Hung Fu Tseng; Jonathan Duffy; Lisa A Jackson; Matthew F Daley; Brad Crane; Huong Q McLean; Steven J Jacobsen
Journal:  Int J Med Inform       Date:  2019-04-13       Impact factor: 4.046

4.  Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Jennifer L Liang; Tejpratap Tiwari; Pedro Moro; Nancy E Messonnier; Arthur Reingold; Mark Sawyer; Thomas A Clark
Journal:  MMWR Recomm Rep       Date:  2018-04-27

5.  Safety Surveillance of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccines.

Authors:  Pedro L Moro; Silvia Perez-Vilar; Paige Lewis; Marthe Bryant-Genevier; Hajime Kamiya; Maria Cano
Journal:  Pediatrics       Date:  2018-06-04       Impact factor: 7.124

Review 6.  Best vaccination practice and medically attended injection site events following deltoid intramuscular injection.

Authors:  Ian F Cook
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

7.  International Consensus (ICON): allergic reactions to vaccines.

Authors:  Stephen C Dreskin; Neal A Halsey; John M Kelso; Robert A Wood; Donna S Hummell; Kathryn M Edwards; Jean-Christoph Caubet; Renata J M Engler; Michael S Gold; Claude Ponvert; Pascal Demoly; Mario Sanchez-Borges; Antonella Muraro; James T Li; Menachem Rottem; Lanny J Rosenwasser
Journal:  World Allergy Organ J       Date:  2016-09-16       Impact factor: 4.084

Review 8.  Sepsis, parenteral vaccination and skin disinfection.

Authors:  Ian F Cook
Journal:  Hum Vaccin Immunother       Date:  2016-06-13       Impact factor: 3.452

9.  Comprehensive assessment of serious adverse events following immunization by health care providers.

Authors:  S Elizabeth Williams; Kathryn M Edwards; Roger P Baxter; Philip S LaRussa; Neal A Halsey; Cornelia L Dekker; Claudia Vellozzi; Colin D Marchant; Peter D Donofrio; Tyler E Reimschisel; Melvin Berger; Jane F Gidudu; Nicola P Klein
Journal:  J Pediatr       Date:  2013-02-26       Impact factor: 4.406

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.